AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Jun 3, 2014
30016_dirs_2014-06-03_e984a0da-f56a-40f3-8f6c-5c2e8b6dbe90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-06-01
Reporting Person: Fiarman Jeffrey (EVP, GEN COUNSEL & SECRETARY)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-01 | Common Stock | M | 728 | — | Acquired | 886 | Direct |
| 2014-06-01 | Common Stock | F | 235 | $128.4800 | Disposed | 651 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-01 | Restricted Stock Unit | $ | M | 728 | Disposed | Common Stock (728) | Direct |
Footnotes
F1: Includes 47 shares, 52 shares and 59 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2013, 12/31/2013, and 03/31/2014 respectively.
F2: Represents restricted stock units previously granted on 06/01/2013 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date of the date of grant (06/01/2013).